Constellation Pharmaceuticals Inc
CNSTDelisted Jul 15, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434418
Constellation Pharmaceuticals Inc was delisted on Jul 15, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 153 institutions reported holding it in 13F filings for Q2 2021, worth $1.48B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Constellation Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Constellation Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hoerter Steven L. | Director | – | Jul 23, 2021 | 0 |
| Goldsmith Mark A | Director | 0 | Jul 19, 2021 | 0 |
| Valentine Karen | See Remarks | – | Jul 19, 2021 | 0 |
| Levy Richard S | Director | – | Jul 19, 2021 | 0 |
| Braunstein Scott | Director | – | Jul 19, 2021 | 0 |
| Reeve Emma | Chief Financial Officer | – | Jul 19, 2021 | 0 |
| Trehu Elizabeth | Director | – | Jul 19, 2021 | 0 |
| Raythatha Jigar | See Remarks | 0 | Jul 19, 2021 | 0 |
| Audia James E | Director | 0 | Jul 19, 2021 | 0 |
| Trojer Patrick | Chief Scientific Officer | – | Jul 19, 2021 | 0 |
| Humphrey Jeffrey | Chief Medical Officer | – | Jul 19, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.